Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum

Neuroscience. 2006 Aug 11;141(1):19-25. doi: 10.1016/j.neuroscience.2006.04.047. Epub 2006 Jun 5.

Abstract

Adenosine is known to modulate the function of neostriatal neurons. Adenosine acting on A(2A) receptors increases the phosphorylation of dopamine- and cAMP-regulated phosphoprotein of M(r) 32 kDa (DARPP-32) at Thr34 (the cAMP-dependent protein kinase [PKA] site) in striatopallidal neurons, and opposes dopamine D2 receptor signaling. In contrast, the role of adenosine A(1) receptors in the regulation of dopamine/DARPP-32 signaling is not clearly understood. Here, we investigated the effect of adenosine A(1) receptors on D(1), D(2) and A(2A) receptor signaling using mouse neostriatal slices. An A(1) receptor agonist, 2-chloro-N(6)-cyclopentyladenosine (100 nM), caused a transient increase, followed by a transient decrease, in DARPP-32 Thr34 phosphorylation. Our data support the following model for the actions of the A(1) receptor agonist. The A(1) receptor-induced early increase in Thr34 phosphorylation was mediated by presynaptic inhibition of dopamine release, and the subsequent removal of tonic inhibition by D(2) receptors of A(2A) receptor/G(olf)/cAMP/PKA signaling. The A(1) receptor-induced late decrease in Thr34 phosphorylation was mediated by a postsynaptic G(i) mechanism, resulting in inhibition of D(1) and A(2A) receptor-coupled G(olf)/cAMP/PKA signaling in direct and indirect pathway neurons, respectively. In conclusion, A(1) receptors play a major modulatory role in dopamine and adenosine receptor signaling.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Adenosine A1 Receptor Agonists
  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Animals
  • Benzazepines / pharmacology
  • Dopamine Antagonists / pharmacology
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Drug Interactions
  • Gene Expression / drug effects
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Neostriatum / cytology
  • Neostriatum / physiology*
  • Phenethylamines / pharmacology
  • Raclopride / pharmacology
  • Receptor, Adenosine A1 / physiology*
  • Receptor, Adenosine A2A / metabolism*
  • Receptors, Dopamine D1 / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Threonine / metabolism
  • Triazines / pharmacology
  • Triazoles / pharmacology
  • Xanthines / pharmacology

Substances

  • Adenosine A1 Receptor Agonists
  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Benzazepines
  • Dopamine Antagonists
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Phenethylamines
  • Receptor, Adenosine A1
  • Receptor, Adenosine A2A
  • Receptors, Dopamine D1
  • Triazines
  • Triazoles
  • Xanthines
  • ZM 241385
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • Threonine
  • 2-chloro-N(6)cyclopentyladenosine
  • Raclopride
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Adenosine